Ali A, Elumalai T, Venkatesulu B, Hekman L, Mistry H, Sachdeva A
BMJ Oncol. 2025; 3(1):e000193.
PMID: 39886173
PMC: 11234997.
DOI: 10.1136/bmjonc-2023-000193.
Spielvogel C, Ning J, Kluge K, Haberl D, Wasinger G, Yu J
Insights Imaging. 2024; 15(1):299.
PMID: 39666257
PMC: 11638435.
DOI: 10.1186/s13244-024-01876-5.
Giesen A, Van den Broeck T, Develtere D, Raskin Y, Wymer K, Eden C
World J Urol. 2024; 42(1):81.
PMID: 38358521
DOI: 10.1007/s00345-024-04771-2.
Ni C, Li J
Heliyon. 2024; 9(12):e22814.
PMID: 38213585
PMC: 10782175.
DOI: 10.1016/j.heliyon.2023.e22814.
Ferrari M, Jimenez-Uribe A, Wang L, Hoeppner L, Murugan P, Hahm E
Oncogene. 2023; 43(7):484-494.
PMID: 38135694
PMC: 10857939.
DOI: 10.1038/s41388-023-02925-x.
Prostate Cancer Local Staging with Magnetic Resonance Imaging.
Lin Y, Johnson L, Fennessy F, Turkbey B
Radiol Clin North Am. 2023; 62(1):93-108.
PMID: 37973247
PMC: 10656475.
DOI: 10.1016/j.rcl.2023.06.010.
Biological role of fructose in the male reproductive system: Potential implications for prostate cancer.
Echeverria C, Oyarzun V, Lopez-Cortes A, Cancino J, Sotomayor P, Goncalves M
Prostate. 2023; 84(1):8-24.
PMID: 37888416
PMC: 10872645.
DOI: 10.1002/pros.24631.
Promotes Prostate Cancer Cell Proliferation and Migration via Activation of p-AKT and Vimentin In Vitro.
Choudhry M, Gamallat Y, Kish E, Seyedi S, Gotto G, Ghosh S
Int J Mol Sci. 2023; 24(7).
PMID: 37047027
PMC: 10094631.
DOI: 10.3390/ijms24076055.
Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate Cancer.
Schwarz S, Nientiedt C, Prigge E, Kaczorowski A, Geisler C, Lucena Porcel C
Pathobiology. 2023; 90(5):312-321.
PMID: 37004506
PMC: 10614482.
DOI: 10.1159/000530430.
Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System.
da Silva A, Toledo L, Fernandes R, Ziroldo A, Sawczyn G, Alarcon S
Ann Surg Oncol. 2023; 30(7):4541-4549.
PMID: 36995451
PMC: 10062252.
DOI: 10.1245/s10434-023-13365-y.
Strategy for PSA progression in patients undergoing salvage radiation for biochemical recurrence after radical prostatectomy.
Saito T, Matsumoto K, Kosaka T, Yasumizu Y, Tanaka N, Takeda T
Int J Clin Oncol. 2023; 28(5):707-715.
PMID: 36929093
DOI: 10.1007/s10147-023-02322-0.
Developing dietary interventions as therapy for cancer.
Taylor S, Falcone J, Cantley L, Goncalves M
Nat Rev Cancer. 2022; 22(8):452-466.
PMID: 35614234
DOI: 10.1038/s41568-022-00485-y.
Current Opinion on the Use of Magnetic Resonance Imaging in Staging Prostate Cancer: A Narrative Review.
Michael J, Neuzil K, Altun E, Bjurlin M
Cancer Manag Res. 2022; 14:937-951.
PMID: 35256864
PMC: 8898014.
DOI: 10.2147/CMAR.S283299.
Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
Wibmer A, Nikolovski I, Chaim J, Lakhman Y, Lefkowitz R, Sala E
Radiology. 2021; 302(3):595-602.
PMID: 34931855
PMC: 8893181.
DOI: 10.1148/radiol.210875.
Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy.
Grageda M, Choy B, Paner G, So J
Asian J Androl. 2021; 23(5):516-519.
PMID: 33753582
PMC: 8451493.
DOI: 10.4103/aja.aja_9_21.
Dr. Answer AI for prostate cancer: Clinical outcome prediction model and service.
Rho M, Park J, Moon H, Lee C, Nam S, Kim D
PLoS One. 2020; 15(8):e0236553.
PMID: 32756597
PMC: 7406030.
DOI: 10.1371/journal.pone.0236553.
Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer.
DE Nobrega M, Ciliao H, Souza M, de Souza M, Serpeloni J, Fuganti P
Genet Mol Biol. 2020; 43(3):e20180329.
PMID: 32484847
PMC: 7271063.
DOI: 10.1590/1678-4685-GMB-2018-0329.
Extraprostatic extension in prostate cancer: primer for radiologists.
Shieh A, Guler E, Ojili V, Paspulati R, Elliott R, Ramaiya N
Abdom Radiol (NY). 2020; 45(12):4040-4051.
PMID: 32390076
DOI: 10.1007/s00261-020-02555-x.
Prognostic Value of Pretreatment MRI in Patients With Prostate Cancer Treated With Radiation Therapy: A Systematic Review and Meta-Analysis.
Woo S, Han S, Kim T, Suh C, Westphalen A, Hricak H
AJR Am J Roentgenol. 2019; 214(3):597-604.
PMID: 31799874
PMC: 7499902.
DOI: 10.2214/AJR.19.21836.
Multiparametric MRI - local staging of prostate cancer and beyond.
Caglic I, Kovac V, Barrett T
Radiol Oncol. 2019; 53(2):159-170.
PMID: 31103999
PMC: 6572496.
DOI: 10.2478/raon-2019-0021.